SCHEMBL1848757

SCHEMBL1848757

O[C](c1ccccn1)C1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.50
ALDH1A1 P00352 4/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 2/20 0.49
LMNA P02545 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
NAPRT Q6XQN6 1/20 0.48
P4HTM Q9NXG6 1/20 0.48
GRM4 Q14833 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
GRM5 P41594 1/20 0.45
KMT2A Q03164 1/20 0.44
CYP1A2 P05177 1/20 0.43
GAA P10253 1/20 0.43
TP53 P04637 1/20 0.42
ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6449861 0.79 CYP3A4 (0.58) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL323668 0.79 ALDH1A1 (0.50) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL4458878 0.78 PKM (0.58) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL5042317 0.76 CYP3A4 (0.58) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL38661039 0.75 CES2 (0.58) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL9843696 0.73 HPGD (0.48) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL5928876 0.71 CES2 (0.57) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL2478991 0.71 CES2 (0.47) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL23340688 0.69 LMNA (0.65) PKMALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL2141120 0.69 LMNA (0.65) PKMALDH1A1RAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321321-A1 TRIAZOLO [4, 5-D]PYRAMIDINE DERIVATIVES AND THEIR USE AS PURINE RECEPTOR ANTAGONISTS Vernalis (R&D) Limited (GB) 2011-05-18 EP disclosed